Inborn errors of human IL-17 immunity underlie chronic mucocutaneous candidiasis - PubMed (original) (raw)
Review
Inborn errors of human IL-17 immunity underlie chronic mucocutaneous candidiasis
Anne Puel et al. Curr Opin Allergy Clin Immunol. 2012 Dec.
Abstract
Purpose of review: Chronic mucocutaneous candidiasis (CMC) is characterized by recurrent or persistent symptomatic infection of the nails, skin and mucosae mostly by Candida albicans. CMC is common in patients with profound primary T-cell immunodeficiency, who often display multiple infectious and autoimmune diseases. Patients with syndromic CMC, including autosomal dominant hyper IgE syndrome (AD-HIES) and autosomal recessive autoimmune polyendocrinopathy syndrome type I (APS-I), display fewer other infections. Patients with isolated CMC (CMCD) rarely display any other severe disease. We review here recent progress in the genetic dissection of these three types of inherited CMC.
Recent findings: Low IL-17 T-cell proportions were reported in patients with AD-HIES bearing heterozygous STAT3 mutations, prone to CMC and staphylococcal diseases, and in a kindred with autosomal recessive CARD9 deficiency, prone to CMC and other fungal infections. High levels of neutralizing autoantibodies against IL-17 cytokines were documented in patients with APS-I presenting with CMC as their only infectious disease. The first three genetic causes of CMCD were then reported: autosomal recessive IL-17RA and autosomal dominant IL-17F deficiencies and autosomal dominant STAT1 gain-of-function, impairing IL-17-producing T-cell development.
Summary: Inborn errors of human IL-17 immunity underlie CMC. Impaired IL-17 immunity may therefore account for CMC in other settings, including patients with acquired immunodeficiency.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Figure 1. Inborn errors of IL-17 immunity underlie chronic mucocutaneous candidiasis
Schematic representation of IL-17 mediated immunity with the cooperation between cells recognizing C. albicans (phagocytes and epithelial cells) and IL-17 cytokine producing cells (T and innate lymphocytes). Upon C. albicans recognition by PRRs (pathogen recognition receptors, including Dectin-1, Dectin-2, or Mincle), the adaptor molecule CARD9 mediates the induction of pro-inflammatory cytokines by myeloid or epithelial cells, such as IL-1β, IL-6 and IL-23. Upon binding to their receptors expressed on T and innate lymphocytes, pro-inflammatory cytokines, such as IL-6 or IL-23, activate T lymphocytes via the transcription factor STAT3 resulting in their differentiation into IL-17-producing T cells. Patients with AR CARD9 deficiency (pink), AD STAT3 deficiency (pink), or AR AIRE deficiency (not represented here) with high levels of neutralizing autoantibodies against IL-17A, IL-17F and/or IL-22 (pink), suffer from syndromic CMC and display impaired IL-17 mediated immunity. Patients with AR IL-17RA or AD IL-17F deficiency and impaired IL-17 response or function, respectively, or with AD STAT1 gain-of-function and impaired development of IL-17 producing T cells suffer from CMCD (in blue).
Similar articles
- IL-17 and infections.
Ling Y, Puel A. Ling Y, et al. Actas Dermosifiliogr. 2014 Oct;105 Suppl 1:34-40. doi: 10.1016/S0001-7310(14)70016-X. Actas Dermosifiliogr. 2014. PMID: 25398490 Review. - Chronic mucocutaneous candidiasis disease associated with inborn errors of IL-17 immunity.
Okada S, Puel A, Casanova JL, Kobayashi M. Okada S, et al. Clin Transl Immunology. 2016 Dec 2;5(12):e114. doi: 10.1038/cti.2016.71. eCollection 2016 Dec. Clin Transl Immunology. 2016. PMID: 28090315 Free PMC article. Review. - Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity.
Puel A, Cypowyj S, Bustamante J, Wright JF, Liu L, Lim HK, Migaud M, Israel L, Chrabieh M, Audry M, Gumbleton M, Toulon A, Bodemer C, El-Baghdadi J, Whitters M, Paradis T, Brooks J, Collins M, Wolfman NM, Al-Muhsen S, Galicchio M, Abel L, Picard C, Casanova JL. Puel A, et al. Science. 2011 Apr 1;332(6025):65-8. doi: 10.1126/science.1200439. Epub 2011 Feb 24. Science. 2011. PMID: 21350122 Free PMC article. - Immunity to infection in IL-17-deficient mice and humans.
Cypowyj S, Picard C, Maródi L, Casanova JL, Puel A. Cypowyj S, et al. Eur J Immunol. 2012 Sep;42(9):2246-54. doi: 10.1002/eji.201242605. Eur J Immunol. 2012. PMID: 22949323 Free PMC article. Review.
Cited by
- Skin manifestations of primary immune deficiency.
Lehman H. Lehman H. Clin Rev Allergy Immunol. 2014 Apr;46(2):112-9. doi: 10.1007/s12016-013-8377-8. Clin Rev Allergy Immunol. 2014. PMID: 23760761 Review. - Inborn errors of immunity and related microbiome.
Hazime R, Eddehbi FE, El Mojadili S, Lakhouaja N, Souli I, Salami A, M'Raouni B, Brahim I, Oujidi M, Guennouni M, Bousfiha AA, Admou B. Hazime R, et al. Front Immunol. 2022 Sep 13;13:982772. doi: 10.3389/fimmu.2022.982772. eCollection 2022. Front Immunol. 2022. PMID: 36177048 Free PMC article. Review. - The clinical, immunological and genetic features of 12 Chinese patients with STAT3 mutations.
Lin L, Wang Y, Sun B, Liu L, Ying W, Wang W, Zhou Q, Hou J, Yao H, Hu L, Sun J, Wang X. Lin L, et al. Allergy Asthma Clin Immunol. 2020 Jul 22;16:65. doi: 10.1186/s13223-020-00462-w. eCollection 2020. Allergy Asthma Clin Immunol. 2020. PMID: 32944025 Free PMC article. - Chronic mucocutaneous candidiasis and connective tissue disorder in humans with impaired JNK1-dependent responses to IL-17A/F and TGF-β.
Li J, Ritelli M, Ma CS, Rao G, Habib T, Corvilain E, Bougarn S, Cypowyj S, Grodecká L, Lévy R, Béziat V, Shang L, Payne K, Avery DT, Migaud M, Boucherit S, Boughorbel S, Guennoun A, Chrabieh M, Rapaport F, Bigio B, Itan Y, Boisson B, Cormier-Daire V, Syx D, Malfait F, Zoppi N, Abel L, Freiberger T, Dietz HC, Marr N, Tangye SG, Colombi M, Casanova JL, Puel A. Li J, et al. Sci Immunol. 2019 Nov 29;4(41):eaax7965. doi: 10.1126/sciimmunol.aax7965. Sci Immunol. 2019. PMID: 31784499 Free PMC article. - The role of IL-17A in axial spondyloarthritis and psoriatic arthritis: recent advances and controversies.
McGonagle DG, McInnes IB, Kirkham BW, Sherlock J, Moots R. McGonagle DG, et al. Ann Rheum Dis. 2019 Sep;78(9):1167-1178. doi: 10.1136/annrheumdis-2019-215356. Epub 2019 Jul 5. Ann Rheum Dis. 2019. PMID: 31278139 Free PMC article. Review.
References
- Kirkpatrick CH. Chronic mucocutaneous candidiasis. Pediatr Infect Dis J. 2001;20(2):197–206. - PubMed
- Lilic D. New perspectives on the immunology of chronic mucocutaneous candidiasis. Curr Opin Infect Dis. 2002;15(2):143–7. - PubMed
- Husebye ES, Perheentupa J, Rautemaa R, Kampe O. Clinical manifestations and management of patients with autoimmune polyendocrine syndrome type I. J Intern Med. 2009;265(5):514–29. - PubMed
- Eyerich K, Eyerich S, Hiller J, Behrendt H, Traidl-Hoffmann C. Chronic mucocutaneous candidiasis, from bench to bedside. Eur J Dermatol. 2010 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous